As AI Costs Climb Indian Enterprises Shift Focus to Smaller Language Models RBIs USDINR Swap Auction Sees Robust Bidding at Double the Notified 5 Billion Amount 401k Millionaire Count Dips but Savings Rates Hit Record Highs Fidelity Data Shows Mixed Trends Japanese Shipbuilding Town Turns to Foreign Workers and AI to Tackle Labor Shortage China Coal Mine Explosion in Shanxi Kills at Least 90 Casts Spotlight on Industry Safety Reid Hoffman and Siddhartha Mukherjee Launch AI Cancer Research Startup Manas AI with 246 Million Funding ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains Lifeway Foods LWAY Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains BNR Q3 2022 Earnings NarrowerThanExpected Loss Fails to Lift Stock DTE Energy Q1 2026 Earnings Earnings Miss Estimates as Costs Pressure Results KLXE Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Decline PAYO Q1 2026 Earnings EPS Surprises to the Upside Stock Slightly Lower After Report SES AI Corporation SES Surges Over 6 as Momentum Builds Above Key Support Four Seasons Education FEDU Surges 79 as Stock Tests Key Resistance Near 1146 New Era Energy Digital Inc Warrants NUAIW Surge Over 7 as Momentum Builds Polyrizon Ltd PLRZ Soars Over 20 Key Levels and Potential Scenarios OKE Shows Stability Near 88 ONEOK Inc Holds Steady Amid Mixed Market Signals ECOR Q1 2026 Earnings EPS Surpasses Estimates by Over 40 Amid Strategic Progress MXCT Q1 2026 Earnings EPS Beats with 5098 Surprise Stock Rises 8 Sensient Technologies Q1 2026 Earnings Strong EPS Beat Drives Stock Gain SVCO Q1 2026 Earnings BetterThanExpected Loss Drives Modest Stock Gain GXAI Q1 2026 Earnings EPS Misses Estimates by 1765 Stock Declines Adamas Trust ADAML Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat on FixedtoFloating Rate Structure Merck Foundation and Ghana First Lady Reinforce LongTerm Healthcare and Education Partnership Piper Sandler PIPR Q1 2026 Earnings EPS Surpasses Expectations with 512 Beat Zevra Therapeutics ZVRA Sheds Over 4 as Stock Tests Key Support Levels